Seth Klarman
Baupost Group
Seth Klarman Elevance Health Inc stake
total: 269
Baupost Group ELV trades
- Total transactions:
- 5
- New positions:
- 1
- Added:
- 3
- Reduced:
- 1
- Held since:
- 2025 Q1
- Held for:
- 5 quarters
- Latest activity:
- 2026 Q1
According to 2026 Q1 report, Seth Klarman holds 1,275,154 Elevance Health Inc (ELV) shares with a market value of roughly $373.30M accounting for 7.30% of the overall portfolio. To date, the estimated cost basis is nearly $362.14 for "buy" trades and estimated average "sell" price is $350.55. Baupost Group first purchased ELV in 2025 Q1, initially acquiring 246,000 shares. Since the initial investment in Elevance Health Inc (ELV), Baupost Group has made 4 more transactions.
When did Seth Klarman buy Elevance Health Inc (ELV)?
Seth Klarman first invested in Elevance Health Inc (ELV) in 2025 Q1 at the reported quarter-end price of $434.96 per share.
What's the cost basis of Baupost Group's ELV stake?
The estimated cost basis for Elevance Health Inc (ELV) stake is around $362.14 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $362.14
- Weighted AVG sell price:
- $350.55
Seth Klarman's historical trades in Elevance Health Inc
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
7.30%
|
1,275,154
|
$292.75
|
$373,301,000
|
+0.46% (+5,852)
|
+0.03%
|
|
2025 Q4
|
8.43%
|
1,269,302
|
$350.55
|
$444,954,000
|
-3.77% (-49,698)
|
-0.36%
|
|
2025 Q3
|
8.90%
|
1,319,000
|
$323.12
|
$426,195,000
|
+114.12% (+703,000)
|
+4.74%
|
|
2025 Q2
|
5.80%
|
616,000
|
$388.96
|
$239,599,000
|
+150.41% (+370,000)
|
+3.48%
|
|
2025 Q1
|
3.06%
|
246,000
|
$434.96
|
$107,000,000
|
new
|
+3.06%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.